Press Release: Stemvax : Innovest Global: Signed Agreement with Cedars-Sinai Medical Center, Provides StemVax the Exclusive Worldwide Rights to Four Key Technologies

StemVax Therapeutics, an Innovest Global Inc. (OTC Pink Current: IVST) (the “Company” or “Innovest”) holding, has been awarded an exclusive worldwide license agreement from Cedars-Sinai Medical Center in Los Angeles, CA, for all of the intellectual property needed to commercialize the StemVax Glioblast brain tumor vaccine.